The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery

Sponsor
Ruijin Hospital
Study ID
NCT06800768
Status
Recruiting
Apply to this trial

Conditions

  • Thyroid Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Study Details

This study aims to investigate the value of 68Ga-FAPI PET/CT in detecting recurrent and metastatic lesions in patients with thyroid cancer after surgery.

Key Dates

First listed
Jan 30, 2025
Start date
Feb 1, 2025
Status verified
Jan 2025
Primary completion
Jan 31, 2030
Completion
Jan 31, 2030

Study Design

Enrollment
40 participants (estimated)

Arms

  • Arm: Patients with suspected recurrence or metastasis of thyroid cancer after surgery

Primary Outcome Measure

Diagnosis of recurrent or metastatic thyroid cancer [ Time Frame: Within 1 week after enrollment ]

Central Contacts

Related Studies